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We report the development and application of a pseudorabies virus-based system for delivery of troponeon, a fluorescent Ca2+
sensor to adult canine cardiomyocytes. The eﬃcacy of transduction was assessed by calculating the ratio of fluorescently labelled
and nonlabelled cells in cell culture. Interaction of the virus vector with electrophysiological properties of cardiomyocytes was
evaluated by the analysis of transient outward current (Ito), kinetics of the intracellular Ca
2+ transients, and cell shortening.
Functionality of transferred troponeon was verified by FRET analysis. We demonstrated that the transfer eﬃciency of troponeon
to cultured adult cardiac myocytes was virtually 100%. We showed that even after four days neither the amplitude nor the kinetics
of the Ito current was significantly changed and no major shifts occurred in parameters of [Ca
2+]i transients. Furthermore, we
demonstrated that infection of cardiomyocytes with the virus did not aﬀect the morphology, viability, and physiological attributes
of cells.
Copyright © 2009 Ja´nos Prorok et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. Introduction
The past decade has witnessed an explosive progress of virus-
based gene delivery technologies. The reason for this is that,
albeit traditional approaches, such as calcium phosphate
precipitation, electroporation, or liposome-mediated gene
transfer perform excellently in immortalized cells of various
origins, they mostly fail in primary cultured cells and
under in vivo conditions. Viruses had millions of years to
evolve several means for eﬀective infection of cells that can
be employed by utilizing viruses as vectors for delivering
exogenous genes to the desired cells. Virus-mediated gene
transfer methods have also become powerful and widely
used experimental tools in cardiovascular research. The most
important prerequisites for successful in vitro gene transfer
into adult cardiomyocytes include high quality of primary
cell culture and an eﬀective transfer vector with limited
cytotoxicity and other side eﬀects. However, adult cardiomy-
ocytes are diﬃcult to transduce using methods that work well
in other systems because cardiac cells do not divide, have a
relatively short lifetime in culture, and are highly sensitive to
toxic eﬀects. Gene transfer methods used in cardiovascular
research can be divided into two groups: physicochemical
and viral vector-based systems. Nonviral methods involve
cationic liposome/plasmid DNA complexes, incubation with
naked DNA, and calcium phosphate precipitation [1, 2].
All of these methods suﬀer from severe limitations such
as cytotoxicity, very low transfection eﬃciency especially in
vivo applications, and short-term expression of transduced
genes due to intracellular degradation of foreign DNA. The
above limitations urged the application of more eﬃcient
virus vector-based approaches for gene delivery to the
cardiovascular system. The following viral systems have
been applied in molecular cardiology: adenovirus vectors
(Ads), adeno-associated viruses (AAVs), retroviruses (RV)
like lentivirus (HIV-1), and herpes simplex virus (HSV-1)-
derived vectors [1, 2]. Currently, Ads and AAVs are the
most frequently used tools for delivering genes into the
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cells of the cardiovascular system, both in vivo and in
vitro [3, 4]. While Ads-based vectors allow relatively highly
eﬃcient delivery of transgenes to cardiac cells, this system
provides only transient expression of transferred genes since
the virus does not integrate into the host genome [5]. The
application of Ads have further limitations including strong
immune responses by the host organism, limited space
for transgene integration, and during adaptation may have
moderately diﬃcult quality control. An additional problem
with Ads systems is related to the infection eﬃciency. The
coxsackie adenovirus receptor (CAR) is a key determinant
for the attachment and cellular uptake of adenoviruses [6].
However, CAR expression is maximal in neonates and gets
reduced rapidly after birth in several organs such as heart,
muscle, and brain resulting in lower penetration rate of
adenovirus vectors [7].
Recombinant AAV vectors are able to eﬀectively trans-
duce foreign genes to a variety of cell types including both
dividing and postmitotic cells in both in vitro and in vivo
experimental systems [8]. The AAV-based systems have a
number of favourable attributes, such as lack of parental
agent pathogenicity and vector-related cytotoxicity, minimal
immunogenicity, and the capacity for stable long-term trans-
gene expression. The main disadvantages of AVV vector-
based approaches include the diﬃculty of producing high-
titer virus stocks of consistent purity and bioactivity, and
the limited packaging capacity of a maximum 4.8 kb insert-
size [9]. Lentivirus-based gene transfer has been reported
in a wide variety of cell types, including cardiomyocytes
[10]. Current lentiviral vectors are capable of transducing
mitotically quiescent cells, particularly within the cardio-
vascular system. The strengths of this system include the
ability of long-term stable transgene expression, an increased
packaging capacity compared with AAV, and the other
commonly used integrating vector [11]. The disadvantages
of lentivirus-based gene delivery systems are the relative
low level of transgene expression and the limited transgene
carrying capacity of the virus.
Pseudorabies virus (PRV), a causative agent of Aujeszky’s
disease of swine, is an alpha-herpesvirus belonging to
family of Herpesviridae. Several previous reports have been
successful in construction of PRVs for delivering foreign
genes to neurons [12]. PRV is especially an important tool
for labelling neural circuits [13], which was combined with
delivery of activity markers to labelled neurons [14].
In this study, we have developed a method for short-term
culture of isolated myocytes that retains their morphological
as well as physiological integrity and a pseudorabies virus
(PRV)-based system for delivery of foreign genes to adult
cardiac muscle cells. Troponeon (TN-L15) [15], an FRET-
based activity marker was selected as a model transgene
system. Troponeon is a genetically-encoded fluorescent Ca2+
sensor that is suitable for the imaging of cellular activity
in neurons, muscle, and cardiac cells. Pseudorabies virus
was modified to disable to replicate on postmitotic cells but
retaining its capacity for high titer multiplication on dividing
cultured epithelial cells. The strengths of the presented
system is a very high gene transfer eﬃciency, low toxic eﬀect,
the capacity for relative long-term transgene expression, and
the delivery of large or multiple transgenes. The suitability of
PRV-based gene delivery technique was evaluated in several
ways. We performed simultaneous measurements in non-
infected control and infected myocytes following isolation
and infection. Retained functionality of the sarcolemmal ion
channels was tested by measuring a characteristic multi-
channel current Ito. Intactness of the excitation-contraction
coupling (ECC) machinery and contractile function was
demonstrated by monitoring intracellular calcium transients
and cell shortening. Finally, undisturbed functioning of the
transmitted gene was verified by FRET monitoring of the
calcium transient currents.
2. Materials andMethods
2.1. Cells and Viruses. The wild type Kaplan strain [16] of
pseudorabies virus (PRV) was used as parent strain for the
generation of recombinant viruses used in this study. Viruses
were propagated on subconfluent monolayer of porcine kid-
ney (PK-15) cells. Cells were grown in DMEM supplemented
with 5% fetal calf serum at 37◦C with 5% CO2. The stocks of
PRV were prepared as follows: PK-15 cells were infected with
PRV at a multiplicity of 1 p.f.u/cell, harvested after 24 hours,
followed by freezing and thawing three times. The cells were
then centrifuged and the pellet discarded. The supernatant
fluid was stored in 400 μL aliquots at −80◦C.
2.2. Reporter Genes. Tn-15 (troponeon), an FRET-based
fluorescent calcium sensor [15], was used as an activity
marker in our experiments. The troponeon gene was placed
under the control of the major immediate early promoter
of human cytomegalovirus (pCMV), which provided a high
level of gene expression. The marker gene expression cassette
also contained simian virus 40 (SV40)-derived sequences
including polyadenylation signal and transcription termina-
tion sequences. In addition, a lacZ gene equipped with the
above regulatory sequences was also used as a reporter gene
for the identification of mutant viruses.
2.3. Construction of Targeting Vectors. In our system, a
typical targeting plasmid contains a marker gene expression
cassette flanked by subcloned viral DNA sequences, which
serves as homologous DNA regions for the insertion of
marker genes via homologous recombination. The DNA
sequences used for mutagenesis and as insertion sites for
reporter genes are listed on Figure 1.
2.3.1. Ribonucleotide Reductase (RR) Gene. The details of
the construction of RR gene targeting vector was described
elsewhere [17]. Briefly, a 5-kbp SalI-F fragment of PRV
DNA containing both subunits of RR gene was isolated
and cloned to pRL494, a palindrome-containing positive
selection vector [18]. This plasmid was cut with ScaI
and MluI restriction endonucleases generating a 1805-bp
deletion, which included a 1789-bp DNA fragment from the
3′ end of large (RR1) and a 7-bp DNA sequence from the
5′ end of small subunit (RR2) of ribonucleotide reductase
gene. Subsequently, free DNA ends were filled up by Klenow
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Figure 1: This panel shows a part of recombinant herpesvirus
genome. To adapt for applicability as virus vector we deleted the two
ribonucleotide reductase (rr) and the early protein (ep0) genes from
the virus genome by homologue recombination. The rr1 and rr2
genes are in charge for production of raw material of viral DNA. The
recombinant virus is not able to productively infect postmitotic cells
without rr genes, while ep0 gene is responsible for virus reactivation
from latency. Troponeon calcium sensor gene was inserted into the
antisense promoter region in two copies.
enzyme followed by attaching an EcoRI linker to the blunt
DNA ends. As a final step, a lacZ gene expression cassette
bracketed by EcoRI sites was subcloned to the EcoRI site of
this plasmid.
2.3.2. Early Protein 0 (EP0) Gene. Generation of EP0 gene
targeting vector was described previously [19]. Briefly, the
9.4-kb KpnI-F DNA fragment containing the EP0 gene was
subcloned into pRL425; followed by cleaving with BamHI
restriction endonuclease, which resulted in the deletion of a
1390-bp sequence, including almost the entire EP0 gene. Free
DNA ends were converted to EcoRI sites via linker insertion
and then religated. The same lacZ gene expression cassette as
above was subcloned to the EcoRI site of this plasmid.
2.3.3. Putative Antisense Promoter (ASP) Region. The 4.9-kb
BamHI-8′ PRV DNA fragment was isolated and subcloned
to pRL525 cloning vector [18, 20]. The DraI site located
in the putative TATAA box of ASP was used for the
insertion of EcoRI thereby destroying its potential function.
The fluorescent marker gene expression cassettes (GFP,
troponeon) were inserted to the EcoRI site of this plasmid.
2.4. Generation and Isolation of Recombinant Viruses.
Recombinant viruses were generated by means of homol-
ogous recombination between parent PRV genomes and
targeting plasmids containing reporter genes bracketed by
virus sequences. Viral DNA was transfected to actively
growing PK-15 cells along with the appropriate targeting
plasmid using lipid-mediated gene delivery (Lipofectamine
2000 Reagent, Invitrogen). Viral DNA for the transfection
was prepared from virions purified from the medium of
infected cells showing total cytopathic eﬀects by isopycnic
centrifugation on a discontinuous gradient, as described pre-
viously [12]. The lacZ gene-expressing viruses were screened
based on their blue plaque appearance in the presence
of 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-
Gal), the chromogenic substrate of β-galactosidase. Blue
plaques were picked and plaque purified to complete homo-
geneity. Plaques formed by recombinant viruses carrying
the fluorescent markers were detected visually on the basis
of their fluorescence. Recombinant viruses were isolated
by 6–15 cycles of plaque purification procedure using a
fluorescence microscope (Olympus IX-71).
2.5. Isolation of Adult Canine Cardiomyocytes. All experi-
ments were conducted in compliance with the Guide for the
Care and Use of Laboratory Animals (USA NIH publication
No. 85-23, revised 1985). The protocols were approved by
the review board of the Committee on Animal Research
(CAR) of the Albert Szent-Gyo¨rgyi Medical University. The
modified protocol for cell isolation was based on established
procedures described earlier in detail [21].
Canine ventricular myocytes were enzymatically disso-
ciated as follows. A portion of the left ventricular wall
containing an arterial branch large enough to cannulate was
perfused in a modified Langendorﬀ apparatus with solutions
in the following sequence:
(1) normal Tyrode’s solution (10 minutes), (2) Ca2+-
free Tyrode solution (10 minutes), and (3) Ca2+-free Tyrode
solution containing collagenase (type I, 0.66 mg/mL) and
bovine serum albumin (fraction V, fatty acid free, 2 mg/mL)
(15 minutes). Protease (type XIV, 0.12 mg/mL) was added
to the final perfusate while and another 15–30 minutes of
digestion was allowed. Cells were stored in KB solution.
The composition of solutions were (in mM): (a) normal
Tyrode’s solution—NaCl 135, KCl 4.7, KH2PO4 1.2, MgSO4
1.2, HEPES 10, NaHCO3 4.4, glucose 10, and CaCl2 1.0 (pH
7.2 adjusted with NaOH); (b) Ca2+-free Tyrode solution—
NaCl 135, KCl 4.7, KH2PO4 1.2, MgSO4 1.2, HEPES 10,
NaHCO3 4.4, Glucose 10, and taurine 20 (pH 7.2 adjusted
with NaOH); (c) KB solution—KOH 90, L-glutamic acid
70, taurine 15, KCl 30, KH2PO4 10, MgCl2 0.5, HEPES 10,
glucose 11, and EGTA 0.5 (pH 7.3 adjusted with KOH). All
chemicals used in this method were purchased from Sigma
Chemical Co.
2.6. Culture and Infection of Myocytes. The entire culture
procedure was performed in a class II flow hood. The
freshly isolated myocytes were centrifuged five times for 1
minute at 50 g in sterile 10% PBS. The supernatant was
replaced first by 500 μM then by 1 mM Ca2+ containing PBS
solution. The mild centrifugation steps removed the majority
of bacterial cells, most nonmyocytes and nonfunctioning
myocytes. Precipitated cells were resuspended in culture
medium and plated on laminin coated (1 μg/cm2) sterile
cover glass at densities of up to 103 rod-shaped cells cm−2.
Cells were left 4 hours to attach to the plate and after this
time period non attached cells were removed. Following
the first medium change, subsequent medium changes
were carried out every day. Culture medium consisted of
serum-free medium 199 (M199) supplemented with 25 mM
NaHCO3, 5 mM ceratine, 2 mM L-carnitine, 5 mM taurine,
100 units/mL insulin (CCTI supplemented medium) and
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50 μg/mL gentamycin. All chemicals used in this procedure
were purchased from Sigma. Cells were maintained at 37◦C
under sterile conditions in an incubator ventilated with 5%
CO2 and 95% air. After 4 hours, plate attached cells were
infected. Freshly isolated canine cardiomyocytes were first
washed with PBS, followed by low-speed centrifugation and
resuspension in culture medium. Subsequently, after a 4-
hour incubation at 37◦C in a CO2 incubator, cells were
infected with various titers of recombinant viruses for 12
hours then washed and the culture medium was changed.
Infected cells were used for analysis at various time points.
2.7. Evaluation of Infection Eﬃcacy and Morphological
Changes in Cultured Cardiomyocytes. Cell shape and mor-
phology are closely linked with some aspects of cell function
such as excitation-contraction coupling. Therefore, monitor-
ing these properties may give indications of physiological
changes that are occurring. Morphological changes of cells
were observed by light microscope on a daily basis parallel
with physiological measurements. Troponeon-positive cells
were examined by fluorescence microscopy from one to
three days following isolation at standard titer of viruses.
Infection eﬃcacy was determined separately for infected
cells by manual cell counting using a fluorescent microscope
(Olympus IX-71).
2.8. Evaluation of the Physiological State of
the Virus-Infected Cells
2.8.1. Evaluation of the Electrophysiological State of the Cells
by Ito Analysis. Ito currents were measured at 37◦C using
the whole-cell configuration of the patch-clamp technique.
Measurements were performed daily starting with day
0, when only freshly isolated noninfected myocytes were
investigated. In the following days control and infected cells
were studied separately by placing cover glasses with the
attached cells in the recording chamber mounted on the stage
of an inverted microscope equipped with epifluorescence
assembly (Olympus IX50, Tokyo, Japan). Only rod-shaped
cells with clear cross-striations and relatively strong GFP
signal were used. HEPES-buﬀered Tyrode’s solution con-
taining (in mM): NaCl 144, NaH2PO4 0.33, KCl 4.0, CaCl2
1.8, MgCl2 0.53, glucose 5.5, and HEPES 5.0 at pH of 7.4
(by NaOH) served as normal superfusate. Cell capacitance
(199.3 ± 13.7 pF, n = 69) was determined by applying
a 10 mV hyperpolarizing pulse from a holding potential
of −10 mV. Cell capacity was calculated as the integral
of the capacitive transient divided by the amplitude of
the voltage step. Patch-clamp micropipettes were fabricated
from borosilicate glass capillaries (Clark, Reading, UK)
using a P-97 Flaming/Brown micropipette puller (Sutter Co,
USA). These electrodes had resistances between 1.5 and
2.5 Mohms when filled with pipette solution containing
(in mM): K-aspartate 100, KCl 45, K2ATP 3, MgCl2 1,
EGTA 10, and HEPES 5. The pH of this solution was
adjusted to 7.2 by KOH. Nisoldipine (1 μM) (obtained as
a gift from the Bayer AG, Leverkusen, Germany) was used
in the external solution to eliminate inward Ca2+ current
(ICa). Membrane currents were recorded with Axopatch-
200B patch-clamp amplifiers (Axon Instruments, USA).
After establishing a high (1–10 Gohm) resistance seal by
gentle suction, the cell membrane beneath the tip of the
electrode was disrupted by suction or by application of 1.5 V
electrical pulses for 1–5 milliseconds. The series resistance
was typically 4–8 Mohm before compensation (50–80%,
depending on the voltage protocols). Experiments where
the series resistance was high, or substantially increased
during measurement, were discarded. Membrane currents
were digitized using a 333 kHz analogue-to-digital converter
(Digidata 1200, Axon Instruments) under software control
(pClamp 8.0, Axon Instruments). Analyses were performed
using pClamp 8.0 (Axon Instruments) software after low-
pass filtering at 1 kHz. All patch-clamp data were collected
at 37◦C.
2.8.2. Evaluation of Cell Function by Monitoring [Ca2+]i
Transient and Cell Shortening. 24–72 hours following viral
infection cultured myocytes were loaded by incubation for
20 minutes with the acetoxymethyl ester (AM) form of a
single wavelength calcium-sensitive fluorescent dye (Fluo-
4, Molecular Probes Inc. 1–2 μM from a stock of 1 mM
in DMSO + 20% pluronic acid) at room temperature.
The technique for calcium transient detection was based
on established procedures described earlier [22]. After this
incubation period the cover glass with attached cultured
myocytes was mounted in a low volume imaging chamber
(RC47FSLP, Warner Instruments, USA) and placed on the
stage of an inverted fluorescent microscope (IX71, Olympus,
Japan). The cells were superfused with normal Tyrode
solution at 37◦C (1 mL/min). Myocytes were stimulated
at a constant frequency of 1 Hz through a pair of plat-
inum electrodes by an electronic stimulator. The dye was
excited at 480 nm, fluorescence emission was recorded at
535 nm (Chroma, USA). Optical signals were recorded
by a photon counting photomultiplier module (H7828,
Hamamatsu, Japan), and sampled at 1 kHz. Measurements
were performed and data were analyzed using the Isosys
software (Experimetria Ltd, Hungary). Cell shortening from
both ends was determined by a video edge detection system
(VED-105, Crescent Electronics, USA). All experiments
were performed at 37◦C, using an automatic temperature
controller (TC-344B, Warner Instruments, USA).
2.8.3. Evaluation of the Functionality of the Transferred Gene
by FRET Measurement. For testing the functionality of
the transferred gene, following the incubation period the
cover glass with the attached primary cultured cardiomy-
ocytes was mounted in a low volume imaging chamber
(RC47FSLP, Warner Instruments, USA) on the stage of
an Olympus IX71 inverted microscope outfitted with a
75 W Xe arc lamp for epi- and a 100 W tungsten-halogen
lamp for transillumination. The myocytes in the chamber
were superfused with normal Tyrode solution (1 mL/min)
and stimulated at a constant frequency of 1 Hz by an
electronic stimulator (Experimetria) through a pair of
platinum electrodes. All measurements were performed at
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37◦C, by using an automatic temperature controller (TC-
344B, Warner Instruments, USA). The optical signals were
typically monitored 20–36 hours after infection in selected
myocytes expressing the genetically encoded FRET-based
sensor troponeon (csTnC-L15). Cells with medium-high
level of fluorescence were selected for measurement. Though
often troponeon fluorescence is already visible 16 hours
following infection, optical signals were found to be optimal
for recording after 24 hours.
Fluorescent optical signals were monitored by a dual
channel photon counting system. An Olympus filter cube
containing a CFP excitation filter (436/20 x) and a CFP
dichroic mirror (455DCLP) but no emission filter was
inserted into the light path of the microscope. A connector
box for dual emission fluorescence with two interchange-
able dichroic mirror holders and three detector ports
(P226/0II/011, Cairn Research Ltd, UK) equipped with
two photons counting photomultiplier modules (H7828,
Hamamatsu, Japan) was attached to the left side port of the
microscope. The fluorescent signal from the microscope was
splitted by a YFP dichroic mirror (515LP). A second dichroic
mirror (565DCLP) was used to separate the longer wave-
length (FRET) fluorescence from the red filtered (> 580 nm)
transillumination light used for visual observation of the
cell by a video camera mounted on the 3rd back port of
the connector box. The splitted fluorescence components
were band pass filtered (480/30 m and 535/30 m for CFP and
citrine, resp.), integrated with 1 milliseconds time resolution
by two photons to voltage converter units (Ionoptics, US)
and collected for data processing. All interference filters and
dichroic mirrors used are avaiable in filter sets 31036V2 and
41028 from Chroma Technology Corporation (US).
Changes in [Ca2+]i levels were characterized by the ratio
of the emitted fluorescence intensities obtained at 480 and
535 nm wavelengths, (FFRET CITRINE 535/ FCFP 480) following
optical signal correction steps for photobleaching and non-
specific background fluorescence. Photobleaching leads to a
steady decrease in the FRET ratio over time, because citrine is
less photostable than CFP. To correct for bleaching, we mul-
tiplied the intensity of the CITRINE channel by a correction
factor calculated from the intensity shift between two time
points. For background correction we subtracted from
the optical signals the nonspecific background fluorescence
determined at both wavelengths by moving oﬀ the cell from
the light path: FRATIO corr = (F− F0)CITRINE / (F− F0)CFP.
The background-corrected fluorescence ratio versus time
curve can be considered as a representation of the intracel-
lular Ca2+ transients Figure 7.
2.9. Data Analysis. All patch-clamp results and optical
measurements were compared using Student’s t-tests for
paired and unpaired data and expressed as mean± SEM val-
ues. Statistical significance of diﬀerences obtained between
control and virus infected preparations was evaluated
with Student’s t-test for paired or unpaired data, as rel-
evant. Diﬀerences were considered significant when P <
.05.
Table 1: This table shows the survival of noninfected and virally
infected cells from day 0 to day 5. It can be seen that virally infected
cells exhibit slightly better survival than noninfected cells, for which
the reason remains to be ascertained.
Day 0 Day 1 Day 2 Day 3 Day 4 Day 5
Control
Average
(%):
100 60,0 44,9 4,3 2,8 2,2
Standard
error:
6,0 8,4 0,5 0,3 0,3
Virus
infected
Average
(%):
100 85,5 69,2 12,8 3,1 1,3
Standard
error:
4,7 9,3 3,7 1,5 0,6
3. Results
3.1. Morphological Changes of Cultured Cardiomyocytes.
Using the described method for isolation of adult dog left
ventricular myocytes, we routinely obtained a high yield
(more than 80%) and high (more than 80%) percentage
of rod-shaped myocytes that were suitable not only for
acute functional studies but, more importantly, for short-
term culture and gene transfer. Figure 2(a) shows a transil-
lumination image of freshly isolated and 1-day-old cultured
cardiomyocytes from the left ventricle. To establish optimal
surviving conditions several culture conditions were tested
based on microscopic evaluation of changes in cellular
morphology during the four days of culture. Cultured cells
were used 1–3 days after isolation. During this period, visible
small-scale changes in cell shape and cross-striation could
be observed. Figure 2(b) shows representative photographs
of canine myocytes over time in culture. Features typical
of acutely isolated (Day 0) cells were the rod shape with
rectangular stepped ends and clear cross-striations. After 1
day (Day 1) in culture, the cells were still rod-shaped with
clear cross-striations; however, the ends of the cells started
to become slightly rounded in appearance. After 3 days (Day
3) in culture, cells remained rod-shaped and cross-striated,
and the main change was that cell ends became progressively
more rounded (see Table 1 for cell survivals).
3.2. Eﬃcacy of Virus Infection in Cultured Cardiomyocytes.
Survival rates were found to be dependent on the isolation
procedure, density of the attached myocytes, and the applied
virus titer. Intriguingly, a higher total number of viable cells
were observed on the laminin-coated surfaces after plating in
CCTI supplemented medium. As respective panels of Figures
2 and 3 (upper panel) show, even after three days, the cell
culture contained a substantial number of good quality cells
both in the control and virus-infected groups. Surprisingly,
a moderately but consistently higher cell survival rate was
found in virus-infected groups as compared to noninfected
groups (not shown). The infection eﬃciency was found to
be 100%, that is 24 hours postinfection every surviving cells
emitted fluorescent signals provided that high dose of virus
was used for the infection (Figure 3 bottom panel).
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Figure 2: Representative low- and high-magnification transillumination of adult dog myocytes after isolation (day 0) and 1–3 days of culture
(day 1, day 3). (a) shows the yield of the myocytes before and one day after culturing and infection. The high-magnification transillumination
(b) shows the morphology of adult dog myocytes after isolation (day 0) and 1–3 day of culture (day 1, day 3) and the morphological changes
of living cells, versus the culturing time from noninfected (right) and the virus-infected groups (left). After one day plated myocytes more
than 80% displayed a rod-shaped morphology and healthy cross-striation. After 3 days (day 3) in culture, cells remained rod-shaped and
partially cross-striated, and the main change was that cell ends became progressively more rounded.
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Figure 3: (a) Representative light and (b) fluorescent microscopic images of cell culture, before and after 1 day and 3 days of virus infection.
Expression of recombinant pseudorabies-viral troponeon transgenes appeared on high level in cultured adult dog ventricular myocytes.
The isolation of adult dog left ventricular myocytes yielded more than 80% living cells. After three days the troponeon expression and the
physiological features of survival myocytes was appropriate for the physiological studies.
3.3. Whole-Cell Patch-Clamp Recordings. The whole-cell
configuration of the patch-clamp technique was used to
record the transient outward Ito current. Ito was chosen as
a physiological assay because it is a large current that can
be measured relatively easily in isolated canine ventricular
myocytes. The current was activated by 300 milliseconds long
depolarizing voltage pulses from the holding potential of−90
mV to test potentials ranging from 0 to +60 mV with a pulse
frequency of 0.33 Hz. The amplitude of Ito was measured as
the diﬀerence between the peak and the sustained current
at the end of the voltage pulse. Figure 4(a) shows typical
recordings of Ito measured after one (Day 1) and three
days (Day 3) of culture either in control (top panels)
or virus-infected cells (bottom). Figure 4(b) summarizes
all Ito measurements performed after 0–4 days of culture
in both groups. As the corresponding panels of Figure 4
show, the amplitude of the Ito was reduced by less than
10% in virus-infected myocytes (VM) compared to control
noninfected cells (CM) even after 4 elapsed days. Moreover
current amplitude was somewhat larger in PRV-infected cells
compared to that of observed in control cells. Mean Ito
density (Figure 4(b)) was similar for CM and VM cells after
1 day. The Ito current density in VM changed in four days
from 19.6 ± 1.4 to 24.6 ± 2.6 pA/pF (n = 10–12), which
corresponds well with that observed in CM (from 19.3± 2.1
to 17.1± 1.5 pA/pF, n = 8–10). Although mean Ito density of
several-day-old (2, 3, 4) cultured myocytes was significantly
larger in VM than CM. The Ito kinetics (activation and
inactivation properties) was also not significantly altered by
the virus infection.
3.4. Parameters of Intracellular Ca2+ Transients and Con-
tractility. Cultured myocytes were stimulated at a constant
frequency of 1 Hz through a pair of platinum electrodes.
Similarly to Ito measurements, the steady-state [Ca
2+]i tran-
sient and contractile function were measured and compared
on a daily basis both in the infected and control cell
populations. Original recordings of [Ca2+]i transients and
cell shortening before and after virus infection are presented
in Figure 5. The calcium transient kinetics were significantly
distorted in culture, but were also not significantly altered
by the virus-infection. As Figure 6 summarizes, we found no
statistically significant diﬀerences in either the amplitude of
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Figure 4: (a) Transient outward K current (Ito) recordings from control and from virus-infected myocytes after (a) 1 and (b) 3 days of
culture. Inset shows applied voltage protocol. (b) shows the Ito current densities from control and from virus-infected myocytes after 1 to 4
days long culture. Data represent means ± SEM, and n represents the number of experiments.
calcium transient (A) or diastolic calcium level (B) between
the studied groups. Moreover, transient decay time (C) in
noninfected control myocytes was significantly larger than in
the virus infected group after two and three days in culture.
Conversely in virus-infected group’s decay time was similar
to freshly isolated cells. The cell-shortening measurements
(D) represent a significant decline in noninfected cell culture
after 1 and 3 days. Data indicate no significant changes in
these parameters.
3.5. Functionality of FRET-Based Calcium Sensor. Freshly
isolated ventricular myocytes were infected with the virus
following 4 hours plating and fluorescence could already
be detected within 16 hours. The functionality of the
transferred gene was verified by monitoring [Ca2+]i. Figure 7
shows two typical fluorescence signal emissions measured in
troponenon-expressed cells obtained at 485 nm and 535 nm
excitation (upper panel). The lower panel shows the ratio of
the citrine and CFP emitted signals representing the changes
of the [Ca2+]i levels in the studied cells. This measurement
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Figure 5: Original Ca2+ transients and cell contraction recording in
cardiomyocytes cultured for 1 and 3 days. The top panel shows the
intracellular Ca2+ concentration as Ca2+ transient fluorescent signal
(F535 nm), and bottom panel shows the changes in cell length.
clearly shows that virally-encoded troponenon retained its
ability of indicating [Ca2+]i levels in cardiomyocytes.
4. Discussion
Recent advances of transgenesis and gene targeting tech-
nologies have heralded a new era of cellular physiology
to study molecular function using genetically engineered
animal models and genetically encoding vector-based gene
transfer systems. Practically, the mouse is the only mam-
malian species in which transgenic technology eﬃciently
works. Several transgenic and gene-targeted models have
been generated for the overexpression [23, 24], and genetic
ablation of key proteins [25, 26] governing cardiac structure
and function.
However, the mouse is not an ideal species for modelling
human disease like heart failure, myocardial infarction, and
arrhythmia studies, because the mouse heart has distinctly
diﬀerent action potential waveform due to its diﬀerent
underlying ionic current structure [27, 28]. Transducing
foreign genes to cardiac cells of living animals is a feasible
technique in several animal models; however, performing
electrophysiological measurements in vivo is not easy there-
fore in vitro electrophysiological techniques are usually used
in cultured cells for this purpose. Similar experiments were
performed in a recently published work using cultured
human atrial myocytes [29] and myocytes isolated from rat, a
species from which producing long-term cell culture is much
easier.
Gene transfer to cardiac myocytes has been traditionally
carried out in neonatal cells. However, these cells undergo
diﬀerentiation, and as a result, this model is inappropriate for
certain experiments since diﬀerentiating cells have diﬀerent
currents than that of from adult cells. Therefore, in vitro
transducing of isolated cardiac myocytes can be a useful
alternative for investigations of cardiovascular cell physiology
and diseases.
The structural changes during culturing ventricular
myocytes were studied and as well [30, 31]. These changes
are associated with culturing procedures associated eﬀects,
which may change a number of physiological properties of
cells in culture. Therefore, some possible alterations in the
Ca2+ handling and sarcolemmal ionic currents may have
been diminished in cultured cells.
Another potential application of our viral gene transfer
strategy is to introduce siRNA for silencing pore or auxiliary
ionic channel subunits underlying transmembrane ionic
currents. In this study we opted for canine model, since
the dog unlike the mouse and rat is known to have action
potential and ionic current characteristics similar to human
[32]. We have chosen the transient outward current for
testing the possible eﬀects of viral infection because Ito is
a relatively large current and present in all cells. Also it
can be relatively easily measured. The Ito gene structure is
rather complex. The Ito current in canine myocytes resembles
human myocytes and has a large conducting pore forming
unit Kv4.3 connected with several auxiliary subunits such as
KChIP2, KCNE2, and DPPX [33]. In the present work, we
measured the eﬀect of the viral infection on Ito and we found
that the virus did not aﬀect either the density or kinetics of
Ito current (Figure 4).
Since their introduction more than twenty years ago
of Ca2+-sensitive fluorescent dyes have been used to evalu-
ate intracellular free calcium concentration ([Ca2+]i) [34],
enabling investigators to gain unprecedented insights into
the mechanisms of cell signalling. The dynamics of changing
Ca2+ concentrations at cellular level and well-defined subcel-
lular spaces in excitable cells, during the course of membrane
depolarization can now be understood in the context of dis-
ease processes such as cardiac arrhythmias and heart failure.
Although many details of excitation-contraction coupling
were described previously, novel quantitative fluorescence
techniques have significantly improved our understanding of
major cell regulatory pathways.
Fluorescent dyes commonly used for Ca2+ imaging
are based on bis(2-aminophenoxy)ethane tetraacetic acid
(BAPTA) structure and subsequently on bis(2-aminoethyl
ether) tetraacetic acid (EGTA) backbone conjugated to a
fluorescent moiety. Fura-2, indo-1, and fluo-4 are the most
widely used fluorescent dyes for monitoring intracellular
[Ca2+]; in their acetoxymethyl ester form they can relatively
easily be loaded into cells, are relatively photostable, and
are well suited for reliable detection of changes in Ca2+
concentration under physiological conditions [35]. These
Ca2+ indicators with low molecular weight have some
important advantages as great dynamic range, increased
sensitivity, high fluorescent intensity, and rapid response
kinetics, but also have some limitations, being not targetable
and subcellular localization of dye cannot be controlled
[36]. Recently developed genetically encoded Ca2+ indicators
(GECIs) are defined as optical Ca2+ sensors produced by
the expression of specific genes. These proteins contain a
light-emitting fluorescent protein unit and a Ca2+-responsive
unit. Troponeon, a typical member of the GECI family is
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Figure 6: This figure shows several parameters of intracellular free calcium transient such as (a) amplitude of calcium transients, (b) diastolic
calcium levels, (c) changes of calcium transient decay constant, and (d) cell-shortening measurements from recordings from control and
from virus infected myocytes after 1 to 3 days long culture. Bars represent means ± SEM, and n represents the number of experiments.
composed of a calcium-binding domain carrying a variant
of troponin C protein and a pair of mutant green fluorescent
proteins (CFP and Citrine) engineered for fluorescence res-
onance energy transfer (FRET) [15]. A significant diﬃculty
in using these new Ca2+ sensors is their low eﬃciency of
transfection into several cell types, cardiomyocytes included.
On the other hand, the strengths of GECIs include the
following: localization can be controlled by a custom signal
sequence; it can be genetically fused to a protein of interest.
GECIs can be maintained within cells over days to weeks
and expression level/concentration of GECIs can be well
controlled by incorporating a promoter [37].
At present, in spite of permanent improvements, tech-
niques for introducing foreign genes to cultured adult
cardiomyocytes suﬀer from substantial limitations, such as
relatively low infection eﬃcacy and/or cell surviving rate
for the integration of transgenes be delivered [38, 39]. In
addition, a number of studies demonstrated that vector
associated cytotoxic eﬀects directly aﬀect a number of
(electro) physiological properties of the cells [1].
In this study, we demonstrated that pseudorabies virus
vectors can eﬀectively penetrate cultured dog cardiomyocytes
and that the transferred foreign gene (troponeon) could be
Citrine 530 nm
CFP 480 nm
(a)
FRATIO corr = (F − F0)CITRINE/(F − F0)CFP
(b)
Figure 7: (a) Original recordings from cells expressed troponeon
at the excitation wavelength of (a) 485 and 535 nm and (b) the
characterized calcium transient by ratio of the fluorescence intensity
(FCFP 485 / FCITRINE 535) from one day after infection.
detected already at 16 hours following infection and until
at least four days postinfection. Furthermore, we showed
that infected cardiomyocytes tolerated the presence of PRV
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vector since their electrophysiological properties were not
fundamentally changed by the virus. The survival of the cells
suitable for electrophysiological studies even after 4 days was
high enough, proving that the virus entered the cells did not
cause any observable substantial cytotoxic eﬀects; moreover
the cells displayed unaltered electrophysiological properties.
This was analyzed by (1) measuring the properties of a
specific transmembrane ionic current, the transient outward
current (Ito), which is known to be ubiquitously present
in all ventricular myocytes; (2) analyzing the intracellular
Ca2+ transient by FRET. In these measurements we found
that Ito was present in all cells even after 72 hours of
viral infection, and neither the density nor the kinetics was
diﬀerent than that of observed in control cells (Figure 4).
On the other hand we found that the kinetics of the
intracellular Ca2+ transient was not significantly diﬀerent
between infected and noninfected cells (Figures 5 and 6).
Specifically, we found that infected adult dog myocytes
had a lower rate of physiological degradation than that
of the noninfected control cell culture in every parameter.
One possible explanation for this unexpected result is
that delayed apoptosis was induced by the virus infection
probably by inactivating the caspase system [40]. Recent
studies have suggested that the latency-associated transcript
(LAT) region of herpes simplex virus type 1 (HSV-1) is
eﬀective at blocking virus-induced apoptosis in vitro in
various cell types [41, 42]. Alternatively, since antiapoptotic
eﬀects depend on intracellular Ca2+ level [43], it is possible
that Ca2+ level was decreased by binding a portion of Ca2+
to troponeon therefore the lower Ca2+ level inhibited cell
death. However, the verification of this eﬀect needs further
investigation.
5. Conclusions
We have developed a PRV-based vector for delivery of
genetically encoded activity sensors to cultured canine
cardiomyocytes. This system has several advantageous fea-
tures: the virus enters to cells without destroying the
intact physiological properties of the cells for a prolonged
period; the virus does not change the measured physio-
logical properties. We tested the survival rate, physiological
changes on ionic current, contractile function, and Ca2+
signalling under eﬀect of virus-mediated gene transfer in
cultured adult canine cardiomyocytes. Our results show
that novel herpesvirus-based vectors can transduce genes
eﬃciently into nondividing cardiac myocytes. Future studies
are required to evaluate, whether PRV will be eﬀective for in
vivo infection for physiological research or gene therapeutic
application.
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